Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Completed Phase 1 Trials for Veliparib (DB07232)

IndicationStatusPhase
DBCOND0029297 (Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00946335ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS TumorsTreatment